News
Verastem (VSTM) stock in focus as Jefferies initiates a Buy rating with a $15 target, citing a potential FDA approval for its ovarian cancer drug combo. Read more here.
City of Hope researchers demonstrate proof of concept for a novel targeted therapy for pancreatic cancer, exploiting ...
Converging computational and laboratory technologies are helping anti-cancer immune responses hit their target more effectively.
We recently published a list of 10 Stocks Under $10 that Will Triple. In this article, we are going to take a look at where ...
Mr. Jim Kras, Chief Executive Officer of Edible Garden, commented, “We are pleased to have regained compliance with the Bid Price Rule, which is a crucial milestone that reflects our team’s continued ...
From new KRAS and HER2 inhibitors to home-administered immunotherapy, recent trials mark a turning point in how metastatic lung cancer is managed.
Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S.
A new study focused on transcription-replication conflicts, which occur when mechanisms responsible for gene expression and ...
Researchers have identified a new molecular target for treating pancreatic cancer. Scientists focused on transcription-replication conflicts (TRCs), which occur when the mechanisms responsible for ...
Researchers at City of Hope have identified a new molecular target for treating pancreatic cancer, reports a Gastroenterology ...
Scientists have identified a key vulnerability in pancreatic cancer by targeting transcription-replication conflicts—cellular ...
3d
Newspoint on MSNNo More Hassle for Mutual Fund KYC—Now Get It Done Right at Home! Follow These Easy StepsIn a major relief for mutual fund investors, the Know Your Customer (KYC) process just got a whole lot simpler! Thanks to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results